UPDATE 1-FDA panel votes to keep severe warning on Pfizer anti-smoking drug
October 16, 2014 at 16:45 PM EDT
Oct 16 (Reuters) - Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.
